logo

For the Inventor, By the Inventor

Zwijnaarde, Belgium

Inbiose N.v.


USPTO Granted Patents = 13



Trademarks = 1

Forward Citations = 2

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Joeri Beauprez (10 out of 13 patents)

silverMedal Jo Maertens (5 out of 8 patents)

bronzeMedal Annelies Vercauteren (4 out of 4 patents)

4.  Marjan De Mey (3 out of 6 patents)

5.  Pieter Coussement (3 out of 3 patents)

6.  Gert Peters (3 out of 3 patents)

7.  Gaspard Lequeux (2 out of 3 patents)

8.  Dries Van Herpe (2 out of 2 patents)

9.  Thomas Decoene (2 out of 2 patents)

10.  Sofie De Maeseneire (1 out of 2 patents)

11.  Eric Timmermans (1 out of 1 patent)

12.  Jyrki Kuusisto (1 out of 5 patents)

13.  Lori Ann Maggio-Hall (1 out of 36 patents)

14.  Steven Cary Rothman (1 out of 17 patents)

15.  Mark J Nelson (1 out of 23 patents)


13 patents:

1. 12715892 - Process for purifying a human milk oligosaccharide and related compositions (2026-08-25),
2. 12378589 - In vivo synthesis of sialylated compounds (2025-08-05),
3. 12344875 - Sialyltransferases for the production of sialylated oligosaccharides (2025-07-01),
4. 12098403 - Metabolically engineered organisms for the production of added value bio-products (2024-09-24),
5. 12077788 - Production of a mixture of neutral non-fucosylated oligosaccharides by a cell (2024-09-03),
6. 12071614 - Increasing activity of 2'fucosyllactose transporters endogenous to microbial cells (2024-08-27),
7. 11913046 - Increasing export of 2'fucosyllactose from microbial cells through the expression of a heterologous nucleic acid (2024-02-27),
8. 11535878 - In vivo synthesis of sialylated compounds (2022-12-27),
9. 11384374 - Metabolically engineered organisms for the production of added value bio-products (2022-07-12),
10. 10858684 - Mutant microorganisms resistant to lactose killing (2020-12-08),
11. 10738336 - Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides (2020-08-11),
12. 10570430 - Metabolically engineered organisms for the production of added value bio-products (2020-02-25),
13. 9951362 - Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides (2018-04-24),
Company Overview
Inbiose N.V., based in Zwijnaarde, Belgium, specializes in the development and production of innovative glycan-based solutions. The company focuses on harnessing the potential of glycans for various applications, particularly in the fields of biopharmaceuticals and nutrition. With a strong emphasis on research and technology, Inbiose aims to advance the understanding and utilization of glycan structures to improve health outcomes and enhance product efficacy. Their expertise positions them as a key player in the biotechnology sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#7 in Zwijnaarde

#214 in Belgium

#44,988 in the World

Zwijnaarde, BE
Zwijnaarde, Belgium

Inbiose N.v.

Forward Citations = 2

26 inventors:

goldMedal Joeri Beauprez (10 out of 13 patents)

silverMedal Jo Maertens (5 out of 8 patents)

bronzeMedal Annelies Vercauteren (4 out of 4 patents)

4.  Marjan De Mey (3 out of 6 patents)

5.  Pieter Coussement (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inbiose N.v.. Retrieved from https://idiyas.com/company/inbiose-n-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…